EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Metabolic labeling of RNA using ribonucleoside analogs enables the evaluation of RNA synthesis and degradation rates

Hidenori Tani

Analytical Sciences · 2025-04 · 41 (4) · 345-351

DOI: 10.1007/s44211-024-00704-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Analytical Sciences, online erschienen am 19.12.2024. Verfasst von Hidenori Tani. Beteiligte Einrichtung: Department of Health Pharmacy, Yokohama University of Pharmacy, 601 Matano, Totsuka, Yokohama, 245-0066, Japan. hidenori.tani@yok.hamayaku.ac.jp. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Ribonucleosides, RNA Stability. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long noncoding RNAs (lncRNAs) are transcripts exceeding 200 nucleotides that do not encode proteins. Despite lacking protein-coding capabilities, lncRNAs play crucial roles in cellular processes, including gene-expression modulation and structural maintenance. The study of lncRNAs has evolved significantly since 2009, with advancements in analytical methodologies providing new insights into their functions and dynamics. Key developments include BRIC-Seq, SLAM-Seq, TUC-Seq, TimeLapse-seq, and Dyrec-Seq. These methodologies have enabled researchers to investigate lncRNA behavior under various conditions, including cellular stress responses and complex biologic systems. Future challenges include developing comprehensive techniques for identifying lncRNA-interacting proteins and advancing in vivo methodologies using model organisms. As the field progresses, integrating these technologies will enhance our understanding of lncRNA biology, potentially leading to novel therapeutic strategies and deeper insights into gene-regulation mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingRibonucleosidesRNA StabilityHumansAnimals

Stichwörter der Autor:innen

BRIC-SeqDyrec-SeqLong noncoding RNASLAM-SeqTUC-SeqTimeLapse-Seq

Substanzen

RNA, Long NoncodingRibonucleosides

Autor:innen und Institutionen

  • Department of Health Pharmacy, Yokohama University of Pharmacy, 601 Matano, Totsuka, Yokohama, 245-0066, Japan. hidenori.tani@yok.hamayaku.ac.jp.

Zitieren

APA

Tani, H. (2025). Metabolic labeling of RNA using ribonucleoside analogs enables the evaluation of RNA synthesis and degradation rates. Analytical Sciences, 41(4), 345-351. https://doi.org/10.1007/s44211-024-00704-6

Vancouver

Tani H. Metabolic labeling of RNA using ribonucleoside analogs enables the evaluation of RNA synthesis and degradation rates. Analytical Sciences. 2025;41(4):345-351. doi:10.1007/s44211-024-00704-6

BibTeX
@article{Tani2025,
  author = {Tani, Hidenori},
  title = {Metabolic labeling of RNA using ribonucleoside analogs enables the evaluation of RNA synthesis and degradation rates},
  journal = {Analytical Sciences},
  year = {2025},
  volume = {41},
  number = {4},
  pages = {345--351},
  doi = {10.1007/s44211-024-00704-6}
}
Kostenlos starten →